nafamostat has been researched along with Gasser Syndrome in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asaka, M | 1 |
| Ishikawa, I | 1 |
| Nakazawa, T | 1 |
| Tomosugi, N | 1 |
| Yuri, T | 1 |
| Suzuki, K | 1 |
1 review available for nafamostat and Gasser Syndrome
| Article | Year |
|---|---|
Hemolytic uremic syndrome associated with influenza A virus infection in an adult renal allograft recipient: case report and review of the literature.
Topics: Adult; Benzamidines; Cyclosporine; Guanidines; Hemolytic-Uremic Syndrome; Humans; Influenza A virus; | 2000 |